✓
Open
4 Aug 2023
✓
Close
8 Aug 2023
3
Allotment
—
✓
Listing
Fri, Aug 18, 2023
Price Band
₹705 to ₹741
Issue Size
2,09,25,652 shares (agg. up to ₹1,551 Cr)
Lot Size
20 Shares
Listing Date
Fri, Aug 18, 2023
Latest GMP
₹122
Est. Gain
16.46%
✦ AI Insight
GMP Trend
18-08-2023₹122Est. ₹863+16.46%
17-08-2023₹122Est. ₹863+16.46%
16-08-2023₹122Est. ₹863+16.46%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 17.64x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 1,513.98 | 1,312.80 | 1,182.55 |
| Total Income | 888.48 | 736.35 | 630.75 |
| Profit After Tax | 240.08 | 174.93 | 234.89 |
| NET Worth | 1,290.00 | 1,103.22 | 999.37 |
| Total Borrowing | 31.24 | 60.59 | 86.35 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,546.00 (-0.06%) |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹42.25 (-4.52%) |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹737.40 (-0.29%) |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹206.05 (-3.04%) |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹95.10 (-4.90%) |
| Trident Lifeline Ltd. | SME | ₹35.34 Cr | ₹101 | 51.53 | ₹108.15 | +7.08% | ₹260.90 (+1.89%) |
| Dipna Pharmachem Ltd. | SME | ₹15.21 Cr | ₹38 | 39 | ₹33.40 | -12.11% | ₹5.40 (-0.74%) |
| JFL Life Sciences Ltd. | SME | ₹18.17 Cr | ₹61 | 26.52 | ₹66.50 | +9.02% | ₹11.00 (+3.77%) |
About Concord Biotech IPO
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022. Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan. The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider. Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.+ Read More
Contact Details
Concord Biotech Ltd. Address1482-86, Trasad Road DholkaAhmedabad, Gujarat, 382225079-6813 8700complianceofficer@concordbiotech.comVisit Website